Faculty

Institution

Unit

Venue

Holly Martinson

University of Alaska Anchorage

Affiliations

College of Health

Medical School

Department Of Family And Community Medicine

University of Alaska Anchorage

NoneHolly Martinson is currently serving as a College Of Health faculty at University of Alaska Anchorage.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Holly Martinson

University of Alaska Anchorage

You can click a keyword to filter the displayed items

immunology cell biology cellular therapy immunotherapy immune responses cancer immunotherapy cancer research oncology immunomodulation therapeutic targets cancer cells tumor targeting gastrointestinal oncology cancer disparities pharmacology experimental medicine molecular cancer cancer care drug targeting pathology gastroenterology medicinal research cell death cell transplantation oncogenes immunologic mechanisms indigenous peoples indigenous studies anti-cancer agents therapeutic vaccines complement c3-targeted liposomes alaska native people parkinson's disease molecular neurodegeneration leukemia digestive diseases pharmaceutics controlled release orthopaedic research violent behavior degenerative disease degenerative pathology breast oncology phagocytes granulocyte cancer genetics immune mediators cellular immune responses novel therapies dating violence traumatology residual stress domestic violence partner violence translational advance translational relevance cancer immunosurveillance macrophage differentiation postpartum breast cancer tumor suppression complement c3 granulocytic myeloid suppressor cells community symposium gastric cancer toll-like receptor agonists immune cells tumor growth intratumoral delivery complement c3-bound liposomes tumor-associated mucin-1 antigen

Notable Scholarly Works

Notable Federal Grants

Collaborators

206 Implementation of a Clinical and Translational Research Pathway for Medical Students at Six Sites Across Washington, Wyoming, Alaska, Montana, and Idaho (Wwami) Regions. Journal of Clinical and Translational Science (2025)

translational researchtranslational advancemedical educationimplementation researchmedicineinternal medicinetranslational relevance

C3-Liposome Delivery of Muc1 Peptide and Tlr Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences. Pharmaceutics (2025)

drug targetingimmunologytherapeutic targetstherapeutic vaccinestumor biologyc3-liposome deliverycancer immunotherapycell biologyimmunotherapycancer researchcancer cellsmuc1 peptideoncogenesmolecular cancercellular therapytumor microenvironmentimmunomodulationimmune responsescancer immunosurveillance

Immunotherapy Platform That Conjugates Antigen to Complement C3-Targeted Liposomes Induces a Robust Adaptive Immune Response. International Journal of Molecular Sciences (2025)

vaccinesimmunologycell biologycell transplantationimmunotherapycellular therapyimmunomodulationimmune responsesimmunologic mechanismscomplement c3-targeted liposomestherapeutic vaccinesimmunotherapy platform

Orthopaedic Injury Patterns in Intimate Partner Violence: Defensive Wounds and Fracture Patterns. JBJS Reviews (2024)

Roan WillsonErika RoddyHolly MartinsonCaitlin Farrell SkeltonLisa Taitsman

orthopaedic researchorthopaedic injury patternsdating violencepsychological traumainjury preventionpsychologyresidual stresswound healingbone fracturetraumadomestic violencetraumatologyorthopedic surgeryinterpersonal violencefracture patternsrehabilitationdefensive woundsorthopaedic surgeryintimate partner violencefamily violenceviolent behaviorpartner violence

Enhancing T Cell and Antibody Response in Mucin-1 Transgenic Mice Through Co-Delivery of Tumor-Associated Mucin-1 Antigen and Tlr Agonists in C3-Liposomes. Pharmaceutics (2023)

t cellcancer immunotherapyimmunologycell biologyimmunotherapycellular therapyimmunomodulationimmune responsescellular immune responsesexperimental medicinemucin-1 transgenic micetumor-associated mucin-1 antigencancer cells

Delivery of Toll-Like Receptor Agonists by Complement C3-Targeted Liposomes Activates Immune Cells and Reduces Tumour Growth. Journal of drug targeting (2021)

cancer immunotherapycell deathimmunologycell biologyimmune mediatorsimmunotherapycellular therapyimmunomodulationimmune cellsimmune responsestherapeutic targetstoll-like receptor agonistscancer cellscomplement c3-targeted liposomesimmunologic mechanisms

Inhibiting Stat3 and Activating Tlr Against Tumors With Opss Liposomes, Curcumin, and Tlr Agonists. Journal of Student Research (2021)

opss liposomestlr agoniststumor targetingdrug targetinganti-cancer agentscancer immunotherapycell signalingimmunologycell biologymolecular cancerpharmacologytherapeutic targetsexperimental medicinecancer cells

Recent Advances in Immune Therapies for Gastric Cancer. Cancer Gene Therapy (2021)

gene therapygastrointestinal oncologycancer immunotherapyimmunologyimmunotherapycellular therapy

Molecular Classification of Gastric Cancer Among Alaska Native People. Cancers (2020)

oncogenespathologygastrointestinal oncologymolecular cancercancer researchcancer geneticsoncology

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease. Frontiers in Neuroscience (2019)

degenerative pathologymolecular neurodegenerationparkinson's diseaseneurosciencemicrobiologyneurodegenerative diseasesdegenerative diseasemicrobiome

1
2
10 / page

Holly Martinson

University of Alaska Anchorage

Affiliations

College of Health

Medical School

Department Of Family And Community Medicine

University of Alaska Anchorage

NoneHolly Martinson is currently serving as a College Of Health faculty at University of Alaska Anchorage.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Holly Martinson

University of Alaska Anchorage

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

translational researchtranslational advancemedical educationimplementation researchmedicineinternal medicinetranslational relevance

C3-Liposome Delivery of Muc1 Peptide and Tlr Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences. Pharmaceutics (2025)

Immunotherapy Platform That Conjugates Antigen to Complement C3-Targeted Liposomes Induces a Robust Adaptive Immune Response. International Journal of Molecular Sciences (2025)

Orthopaedic Injury Patterns in Intimate Partner Violence: Defensive Wounds and Fracture Patterns. JBJS Reviews (2024)

Roan WillsonErika RoddyHolly MartinsonCaitlin Farrell SkeltonLisa Taitsman

Enhancing T Cell and Antibody Response in Mucin-1 Transgenic Mice Through Co-Delivery of Tumor-Associated Mucin-1 Antigen and Tlr Agonists in C3-Liposomes. Pharmaceutics (2023)

Delivery of Toll-Like Receptor Agonists by Complement C3-Targeted Liposomes Activates Immune Cells and Reduces Tumour Growth. Journal of drug targeting (2021)

Inhibiting Stat3 and Activating Tlr Against Tumors With Opss Liposomes, Curcumin, and Tlr Agonists. Journal of Student Research (2021)

Recent Advances in Immune Therapies for Gastric Cancer. Cancer Gene Therapy (2021)

gene therapygastrointestinal oncologycancer immunotherapyimmunologyimmunotherapycellular therapy

Molecular Classification of Gastric Cancer Among Alaska Native People. Cancers (2020)

oncogenespathologygastrointestinal oncologymolecular cancercancer researchcancer geneticsoncology

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease. Frontiers in Neuroscience (2019)

degenerative pathologymolecular neurodegenerationparkinson's diseaseneurosciencemicrobiologyneurodegenerative diseasesdegenerative diseasemicrobiome

1
2
10 / page